Trials / Completed
CompletedNCT06393309
Levetiracetam Versus Valproate in Idiopathic Generalized Epilepsy
Investigation of Long-term Outcome of Levetiracetam and Valproate in Treatment of Idiopathic Generalized Epilepsy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 169 (actual)
- Sponsor
- Mazandaran University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to compare the long-term efficacy and safety of levetiracetam and valproate in treatment of idiopathic generalized epilepsy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levetiracetam | Patients with idiopathic generalized epilepsy who were under treatment with levetiracetam |
| DRUG | Sodium valproate | Patients with idiopathic generalized epilepsy who were under treatment with valproate |
Timeline
- Start date
- 2022-09-03
- Primary completion
- 2024-03-19
- Completion
- 2024-03-19
- First posted
- 2024-05-01
- Last updated
- 2024-05-02
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT06393309. Inclusion in this directory is not an endorsement.